Nautilus Biotechnolgy, Inc. Common Stock
Symbol: NAUT (NASDAQ)
0.74
▲ (10.30%) 0.069
Company Description:
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Key Stats
- Today's Open: $0.73
- Today's High: $0.777
- Today's Low: $0.7
- Today's Volume: 647.44K
- Yesterday Close: $0.67
- Yesterday High: $0.72
- Yesterday Low: $0.6603
- Yesterday Volume: 231.82K
- Last Min Volume: 0
- Last Min High: $0.739
- Last Min Low: $0.732
- Last Min VWAP: $0
Company Profile
- Name: Nautilus Biotechnolgy, Inc. Common Stock
- Website: https://www.nautilus.bio
- Listed Date: 2021-06-10
- Location: SEATTLE, WA
- Market Status: Active
- CIK Number: 0001808805
- SIC Code: 3826
- SIC description: LABORATORY ANALYTICAL INSTRUMENTS
- Market Cap: $88.54M
- Round Lot: 100
- Outstanding Shares: 126.31M
- Asset Type: CS
RECENT FILINGS FOR NAUT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-24 | SCHEDULE 13D/A | View |
| 2025-06-23 | 8-K | View |
| 2025-06-02 | 4 | View |
| 2025-05-12 | 4 | View |
| 2025-05-02 | 8-K | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-29 | 10-Q | View |
| 2025-04-29 | 8-K | View |
| 2025-03-21 | 4 | View |
Latest News on NAUT